Characterization of New Human Models of Non-histaminergic Itch
NCT04515056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2021-07-09
Summary
In this experiment the investigators would like to test a new new human itch model based on papain, and to characterize the sensory quality and temporary aspects of papain skin prick test (SPT) in comparison to the inactivated-cowhage delivery system.
Conditions
- Papain
- Itch
- Skin Prick Test (SPT)
Interventions
- DRUG
-
Papain 10 µg
The area will be exposed to 10 µg of papain.
- DRUG
-
Papain 50 µg
The area will be exposed to 50 µg of papain.
- DRUG
-
Papain 100 µg
The area will be exposed to 100 µg of papain.
- OTHER
-
Vehicle
The area will be exposed to vehicle
- DRUG
-
Papain 1 SPT
Papain will be applied by 1 SPT prick thought the skin
- DRUG
-
Papain 5 SPT
Papain will be applied by 5 SPT pricks thought the skin
- DRUG
-
Papain 25 SPT
Papain will be applied by 25 SPT pricks thought the skin
- OTHER
-
Cowhage
The last area will be exposed to cowage spicules (made chemically inert by autoclaving) soaked in 5 mg/ml papain solution.
Sponsors & Collaborators
-
Aalborg University
lead OTHER
Principal Investigators
-
Silvia Lo Vecchio · Aallborg University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2021-06-01
- Completion
- 2021-06-01
Countries
- Denmark
Study Locations
More Related Trials
-
Study To Evaluate Safety, Tolerability, And Pharmacokinetics Of PF-06473871 In Normal Healthy Adults
NCT01753791 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess ACH-0145228 When Administered as Immediate Release Tablet Versus Powder-In-Capsule in Healthy Adult Participants
NCT04551586 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults
NCT05890105 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Multiple-Dose Escalation and Single Dose (Tablet) Study of PF-04171327 in Healthy Volunteers
NCT00812825 ·Status: COMPLETED ·Phase: PHASE1
-
First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979
NCT02509117 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 Co-administered With Trimethobenzamide Hydrochloride in Healthy Subjects
NCT02262767 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-55375515 in Healthy Male Participants
NCT03405441 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Food Effect on Pharmacokinetics of HMPL-523 Acetate Tablets
NCT07348133 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Healthy Males
NCT02306876 ·Status: TERMINATED ·Phase: PHASE1
-
A Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Multiple Oral Doses Of PF-04895162
NCT01691274 ·Status: COMPLETED ·Phase: PHASE1
-
To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-04531083 In Healthy Male Subjects
NCT00992316 ·Status: COMPLETED
-
STUDY OF PF-07321332 IN HEALTHY PARTICIPANTS
NCT04756531 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects
NCT01140672 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-human Phase 1 Study of CP1050
NCT03468413 ·Status: UNKNOWN ·Phase: PHASE1
-
Relative Bioavailability and Food Effect Study
NCT00827515 ·Status: WITHDRAWN ·Phase: PHASE1
-
A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult Participants
NCT05434091 ·Status: WITHDRAWN ·Phase: PHASE1
-
Multiple Dose Escalation Trial Of PF-04308515 In Healthy Volunteers
NCT01101932 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Dose Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04457845 in Healthy Volunteers
NCT00836082 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers
NCT00875628 ·Status: TERMINATED ·Phase: PHASE1
-
A Study To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-03864086 In Healthy Male Subjects
NCT00747058 ·Status: COMPLETED ·Phase: PHASE1
-
Group Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of PF-04531083 In Healthy Subjects
NCT01012310 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study to Determine the Safety and Pharmacokinetics of FP01 Lozenges in Healthy Volunteers
NCT01579526 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China
NCT03617510 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of FTP-198 Tablet in Healthy Chinese Volunteers
NCT04687813 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants.
NCT07016464 ·Status: TERMINATED ·Phase: PHASE1